Extendicare (TSE:EXE) Given New C$32.00 Price Target at Canadian Imperial Bank of Commerce

Extendicare (TSE:EXEFree Report) had its price objective upped by Canadian Imperial Bank of Commerce from C$22.00 to C$32.00 in a research note published on Thursday morning,BayStreet.CA reports.

Several other analysts have also weighed in on the company. BMO Capital Markets upped their price objective on Extendicare from C$24.00 to C$30.00 in a report on Monday, March 2nd. Royal Bank Of Canada raised Extendicare from a “hold” rating to a “moderate buy” rating and lifted their target price for the stock from C$15.00 to C$25.00 in a report on Thursday, December 4th. Cormark boosted their price target on shares of Extendicare from C$25.00 to C$30.00 in a research report on Wednesday, December 3rd. Canaccord Genuity Group upped their price target on shares of Extendicare from C$20.00 to C$22.50 in a report on Thursday, December 4th. Finally, National Bank Financial raised their price objective on shares of Extendicare from C$24.50 to C$29.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of C$26.79.

Get Our Latest Stock Report on EXE

Extendicare Stock Performance

EXE opened at C$27.76 on Thursday. The company has a market capitalization of C$2.62 billion, a price-to-earnings ratio of 24.94 and a beta of 1.30. The company has a debt-to-equity ratio of 91.85, a current ratio of 1.37 and a quick ratio of 0.98. Extendicare has a 1-year low of C$12.12 and a 1-year high of C$27.89. The business has a 50 day moving average price of C$25.22 and a two-hundred day moving average price of C$20.92.

Extendicare (TSE:EXEGet Free Report) last issued its quarterly earnings results on Thursday, February 26th. The company reported C$0.29 earnings per share (EPS) for the quarter. Extendicare had a return on equity of 47.65% and a net margin of 5.82%.The firm had revenue of C$462.03 million during the quarter. Research analysts predict that Extendicare will post 0.6134729 EPS for the current fiscal year.

About Extendicare

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.

Recommended Stories

Analyst Recommendations for Extendicare (TSE:EXE)

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.